Horuk; Richard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Horuk; Richard.The latest application filed is for "piperazine urea derivatives for the treatment of endometriosis".

Company Profile

0.11.14

Horuk; Richard - Lafayette CA
Horuk, Richard - Belmont CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Piperazine urea derivatives for the treatment of endometriosis App 20080119471 - Kaufmann; Ulrike ; et al.	2008-05-22
Piperazine derivatives and their use as anti-inflammatory agents Grant 7,268,140 - Bauman , et al. September 11, 2	2007-09-11
Piperazine derivatives and their use as anti-inflammatory agents App 20060135487 - Bauman; John G. ; et al.	2006-06-22
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,977,258 - Bauman , et al. December 20, 2	2005-12-20
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,972,290 - Bauman , et al. December 6, 2	2005-12-06
Chemokine inhibiting piperazine derivatives and their use to treat multiple myeloma App 20050192282 - Choi, Sun Jin ; et al.	2005-09-01
Radiopharmaceuticals for diagnosing Alzheimer's disease Grant 6,872,381 - Hilger , et al. March 29, 2	2005-03-29
Non-peptide CCR1 receptor antagonists for the treatment of progressive renal fibrosis Grant 6,812,230 - Horuk November 2, 2	2004-11-02
Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection Grant 6,740,636 - Horuk May 25, 2	2004-05-25
Radiopharmaceuticals for diagnosing Alzheimer's disease Grant 6,676,926 - Hilger , et al. January 13, 2	2004-01-13
Piperazine derivatives and their use as anti-inflammatory agents App 20030158205 - Bauman, John G. ; et al.	2003-08-21
Piperazine derivatives and their use as anti-inflammatory agents App 20030139425 - Bauman, John G. ; et al.	2003-07-24
Non-peptide CCR1 receptor antagonists for the treatment of progressive renal fibrosis App 20030109534 - Horuk, Richard	2003-06-12
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,555,537 - Bauman , et al. April 29, 2	2003-04-29
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,541,476 - Bauman , et al. April 1, 2	2003-04-01
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,534,509 - Bauman , et al. March 18, 2	2003-03-18
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus App 20030008376 - Doms, Robert W. ; et al.	2003-01-09
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus App 20030008391 - Doms, Robert W. ; et al.	2003-01-09
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus App 20030008279 - Doms, Robert W. ; et al.	2003-01-09
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus App 20030003447 - Doms, Robert W. ; et al.	2003-01-02
Piperazine derivatives and their use as anti-inflammatory agents App 20020177598 - Bauman, John G. ; et al.	2002-11-28
Radiopharmaceuticals for diagnosing alzheimer's disease App 20020131932 - Hilger, Christoph-Stephan ; et al.	2002-09-19
Methods And Compositions For Modulating The Interaction Between The Apj Receptor And The Hiv Virus App 20020062488 - DOMS, ROBERT W. ; et al.	2002-05-23
Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection App 20020039997 - Horuk, Richard	2002-04-04
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,207,665 - Bauman , et al. March 27, 2	2001-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.